Letter | Published:

Effects of Lysergic Acid Diethylamide on the Total Leukocytes and Eosinophils of the Female Rat

Naturevolume 199pages11941195 (1963) | Download Citation

Subjects

Abstract

THE hallucinogenic drug, lysergic acid diethylamide (LSD-25), produces in minute doses marked aberrations in mental functions. The psychic symptoms of LSD-25 intoxication resemble aspects peculiar to schizophrenia1,2. As a result, the drug has been utilized as an effective tool to explore the induction of reversible psychoses in non-psychotic subjects. It has been assumed that the similarities produced by LSD-25 could yield information pertinent to the mechanisms and pathophysiology involved in schizophrenia2,3.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Forrer, G. R., and Goldner, R. D., Arch. Neurol. Psychiat., 65, 581 (1951).

  2. 2

    Lingjaerde, P., and Skaug, O. E., J. Nerv. Mental Dis., 124, 578 (1956).

  3. 3

    Sackler, A. M., Sackler, R. R., Marti-Ibanez, F., and Sackler, M. D., J. Clin. and Exp. Psychopath., 15, 382 (1954).

  4. 4

    Härkönen, P., and Konttinen, Y., Acta Pharm. Toxicol., 14, 104 (1958).

  5. 5

    Feld, M., Goodman, J. R., and Guido, J. A., J. Nerv. Mental Dis., 126, 176 (1958).

  6. 6

    Gordon, A. S., Ann. N.Y. Acad. Sci., 59, 907 (1955).

  7. 7

    Rothlin, C., Cerletti, A., Konzett, H., Schalch, W. R., and Taeschler, M., Experientia, 12, 154 (1956).

  8. 8

    Lovell, R. R. H., Osborne, J. A., Goodman, H. C., and Hudson, B., Lancet, i, 970 (1953).

  9. 9

    Milkovic, S., and Supek, Z., Arch. Exp. Path. Pharmakol., 228, 146 (1956).

  10. 10

    Belsanti, E., Acta Neurologica, 7, 340 (1952).

  11. 11

    Todd, J. E., and Sanford, A. H., Clinical Diagnosis, tenth ed. (W. B. Saunders, Philadelphia, 1944).

  12. 12

    Hennenman, P. H., Wexler, H., and Westerhaver, M. M., J. Lab. Clin. Med., 34, 1017 (1949).

  13. 13

    Sackler, M. D., Sackler, R. R., Sackler, A. M., and van Ophuijsen, J. H. W., Amer. J. Psychiat., 108, 669 (1952).

  14. 14

    Altschule, M. D., New Eng. J. Med., 257, 919 (1957).

  15. 15

    Sackler, M. D., Sackler, R. R., Sackler, A. M., Co Tui, and van Ophuijsen, J. H. W., Acta Psychiat. Neurol. Scand., 26, 415 (1951).

  16. 16

    Sackler, M. D., Sackler, R. R., Sackler, A. M., La Burt, H. A., van Ophuijsen, J. H. W., and Co Tui, Psychiat. Quart., 25, 213 (1951).

  17. 17

    Sackler, A. M., Sackler, R. R., Marti-Ibanez, F., and Sackler, M. D., J. Clin. and Exp. Psychopath., 15, 382 (1954).

  18. 18

    Sackler, M. D., Sackler, R. R., Marti-Ibanez, F., and Sackler, A. M., Quart. Rev. Psychiat. and Neurol., 17, 297 (1956).

  19. 19

    Sackler, A. M., Weltman, A. S., and Jurtshuk, jun., P., Aerospace Medicine, 31, 749 (1960).

  20. 20

    Weltman, A. S., Sackler, A. M., and Gennis, J., J. App. Physiol., 16, 587 (1961).

Download references

Author information

Affiliations

  1. Laboratories for Therapeutic Research, Research Institute of the Brooklyn College of Pharmacy, Long Island University, Brooklyn, New York

    • A. M. SACKLER
    • , A. S. WELTMAN
    •  & S. B. SPARBER

Authors

  1. Search for A. M. SACKLER in:

  2. Search for A. S. WELTMAN in:

  3. Search for S. B. SPARBER in:

About this article

Publication history

Issue Date

DOI

https://doi.org/10.1038/1991194a0

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.